Downregulated CD44 and hyaluronan expression in vulvar intraepithelial neoplasia and squamous cell carcinomas

References

• van de Nieuwenhof HP, van der Avoort IAM, de Hullu JA. Review of squamous premalignant vulvar lesions. Oncol Hematol. 2008;68:131–56.
   PubMed Web of Science ®Google Scholar
• Fox H, Wells M. Recent advances in the pathology of the vulva. Histopathol. 2003;42:209–16.
   PubMedGoogle Scholar
• Tammi MI, Day AJ, Turley EA. Hyaluronan and homeostasis: a balancing act. J Biol Chem. 2002;277:4581–4.
   PubMed Web of Science ®Google Scholar
• Laurent TC, Laurent UB, Fraser JR. Functions of hyaluronan. Ann Rheum Dis. 1995;54:429–32.
   PubMed Web of Science ®Google Scholar
• Menzel EJ, Farr C. Hyaluronidase and its substrate hyaluronan: biochemistry, biological activities and therapeutic uses. Cancer Let. 1998;131:3–11.
   PubMed Web of Science ®Google Scholar
• Rooney P, Kumar S, Ponting J, Wang M. The role of hyaluronan in tumour neovascularisation (review). Int J Cancer. 1995;60:632–6.
   PubMed Web of Science ®Google Scholar
• Toole BP. Hyaluronan promotes the malignant phenotype. Glycobiol. 2002;12:37–42.
   Web of Science ®Google Scholar
• Lipponen P, Aaltomaa S, Tammi R, Tammi M, Ågren U, Kosma VM. High stromal hyaluronan level is associated with poor differentiation and metastasis in prostate cancer. Eur J Cancer. 2001;37:849–56.
   PubMed Web of Science ®Google Scholar
• Anttila MA, Tammi RH, Tammi MI, Syrjänen KJ, Saarikoski SV, Kosma VM. High levels of stromal hyaluronan predict poor disease outcome in epithelial ovarian cancer. Cancer Res. 2000;60:150–5.
   PubMed Web of Science ®Google Scholar
• Auvinen P, Tammi R, Parkkinen J, Tammi M, Ågren U, Johansson R, Hyaluronan in peritumoural stroma and malignant cells associates with breast cancer spreading and predicts survival. Am J Pathol. 2000;156:529–36.
   PubMed Web of Science ®Google Scholar
• Ropponen K, Tammi M, Parkkinen J, Eskelinen M, Tammi R, Lipponen P, Tumour cell-associated hyaluronan as an unfavourable prognostic factor in colorectal cancer. Cancer Res. 1998;58:342–7.
   PubMed Web of Science ®Google Scholar
• Setälä LP, Tammi MI, Tammi RH, Eskelinen MJ, Lipponen PK, Ågren UM, Hyaluronan expression in gastric cancer cells is associated with local and nodal spread and reduced survival rate. Br J Cancer. 1999;79:1133–8.
   PubMed Web of Science ®Google Scholar
• Kosunen A, Ropponen K, Kellokoski J, Pukkila M, Virtaniemi J, Valtonen H, Reduced expression of hyaluronan is a strong indicator of poor survival in oral squamous cell carcinoma. Oral Oncol. 2004;40:257–63.
   PubMed Web of Science ®Google Scholar
• Hirvikoski P, Tammi R, Kumpulainen E, Virtaniemi J, Parkkinen J, Tammi M, Irregular expression of hyaluronan and its CD44 receptor is associated with metastatic phenotype in laryngeal squamous cell carcinoma. Virchows Arch. 1999;434:37–44.
   PubMed Web of Science ®Google Scholar
• Knudson W, Chow G, Knudson CB. CD-44-mediated uptake and degradation of hyaluronan. Matrix Biol. 2002;21:15–23.
   PubMed Web of Science ®Google Scholar
• Joensuu H, Ristamäki R, Klemi PJ, Jalkanen S. Lymphocyte homing receptor (CD44) expression is associated with poor prognosis in gastrointestinal lymphoma. Br J Cancer. 1993;68:428–32.
   PubMed Web of Science ®Google Scholar
• Kauffmann M, Heider KH, Sinn HP, von Minkwitz G, Ponta H, Herrlich P. CD44 variant exon epitopes in primary breast cancer and legth of survival. Lancet. 1995;345:615–19.
   Google Scholar
• Kainz CH, Kohleberger P, Sliutz G, Tempfer C, Heinzl H, Reinthaller A, Splice variants of CD44 in human cervical cancer stage IB to IIB. Gynecol Oncol. 1995;57:383–7.
   Google Scholar
• Underhill C. CD44: the hyaluronan receptor. J Cell Sci. 1992;103:293–8.
   PubMed Web of Science ®Google Scholar
• Ropponen KM, Eskelinen MJ, Lipponen PK, Alhava E, Kosma VM. Expression of CD44 and variant proteins in human colorectal cancer and its relevance for prognosis. Scand J Gastroenterol. 1998;33:301–9.
   PubMed Web of Science ®Google Scholar
• Tempfer C, Gitsch G, Haeusler G, Reinthaller A, Koelbl H, Kainz C. Prognostic value of immunohistochemically detected CD44 expression in patients with carcinoma of the vulva. Cancer. 1996;15:273–7.
   Google Scholar
• Hefler LA, Concin N, Mincham D, Thompson J, Swarte NB, van Ejkeren MA, The prognostic value of immunohistochemically detected CD44v3 and CD44v6 expression in patients with surgically staged vulvar carcinoma. Cancer. 2002;94:125–30.
   Google Scholar
• Tempfer C, Gitsch G, Hanzal E, Reinthaller A, Koelbl H, Kainz CH. Expression of the adhesion molecule CD44v3 is a prognostic factor in vulvar carcinoma. Anticancer Res. 1996;16:2029–31.
   Google Scholar
• Tempfer C, Sliutz G, Hausler P, Speiser P, Reinthaller A, Breitenecker G, C44v3 and v6 variant isoform expression correlates with poor prognosis in early-stage vulvar cancer. Br J Cancer. 1998;78:1091–4.
   Google Scholar
• Rodriguez-Rodriguez L, Sancho-Torres I, Gibbon DG, Watelet LF, Mesonero C. CD44-9v and CD44-10v are potential molecular markers for squamous cell carcinoma of the vulva. J Soc Gynecol Investig. 2000;7:70–5.
   Google Scholar
• Sobin LH, Wittekind CH. In: TNM classification of malignant tumours, 6th edn. Geneva Switzerland: UICC, 2002. pp.146–9.
   Google Scholar
• Tavassoli FA, Devilee P. In WHO Health Organization Classification of tumours. Pathology & Genetics. Tumours of the breast and female genital organs. Lyon, France: IARC Press; 2003. pp.314–20.
   Google Scholar
• Wang C, Tammi M, Tammi R. Distribution of hyaluronan and its CD44 receptor in the epithelia of human skin appendages. Histochemistry. 1992;98:105–12.
   PubMedGoogle Scholar
• Ingle RK, Jennings TA, Goodman ML, Pilch BZ, Bergman S, Ross JS. CD44 expression in sinonasal inverted papillomas and associated squamous cell carcinoma. Am J Clin Pathol. 1998;109:309–14.
   Google Scholar
• Wang C, Tammi M, Guo H, Tammi R. Hyaluronan distribution in the normal epithelium of esophagus, stomach, and colon and their cancers. Am J Pathol. 1996;148:1861–9.
   PubMed Web of Science ®Google Scholar
• Karvinen S, Kosma VM, Tammi MI, Tammi R. Hyaluronan, CD44 and versican in epidermal keratinocyte tumours. Br J Dermatol. 2003;148:86–94.
   Google Scholar
• Kunishi M, Kayada Y, Yoshiga K. Down-regulated expression of CD44 variant 6 in oral squamous cell carcinomas and its relationship to metastasis. Int J Oral Maxillofac Surg. 1997;26:280–3.
   PubMedGoogle Scholar
• Ue T, Yokozaki H, Kagai, Higashikawa K, Yasui W, Sugiyama M, Reduced expression of CD44 variant exons by primary and metastatic oral squamous carcinomas. J Oral Pathol Med. 1998;27:303–7.
   Google Scholar
• Oliveira DT, Sherrif M, Odell EW. Expression of CD44 variant exons by primary and metastatic oral squamous carcinomas. J Oral Pathol Med. 1998;27:303–7.
   Google Scholar
• Stoll C, Baretton G, Soost, Terpe HJ, Domide P, Lohrs U. Prognostic importance of the expression of CD44 splice variants in oral squamous cell carcinomas. Oral Oncol. 1999;35:484–9.
   Google Scholar
• Saegusa M, Hashimura M, Machida D, Okayasu I. Down-regulation of CD44 standard and variant isoforms during the development and progression of uterine cervical tumours. J Pathol. 1999;187:173–83.
   Google Scholar
• Callagy G, O'Grady A, Butler D, Leader M, Kay E. Expression of CD44 in uterine cervical squamous neoplasia: A predictor of microinvasion? Gyn Oncol. 2000;76:73–9.
   Google Scholar
• Tammi R, Rilla K, Pienimäki J-P, MacKallum D, Hogg M, Luukkonen M, Hyaluronan enters keratinocytes by a novel endocytic route for catabolism. J Biol Chem. 2001;37:35111–22.
   Google Scholar
• Pirinen RT, Tammi RH, Tammi MI, Pääkkö PK, Parkkinen JJ, Ågren UM, Expression of hyaluronan in normal and dysplastic bronchial epithelium and in squamous cell carcinoma of the lung. Int J Cancer. 1998;79:251–5.
   Google Scholar
• Kaya G, Rodriguez I, Jorcano J, Vassali P, Stamenkovic I. Selective suppression of CD44 in keratinocytes of mice bearing an antisense CD44 transgene driven by a tissue-spesific promoter disrupts hyaluronate metabolism in the skin and impairs keratinocyte proliferation. Genes Dev. 1997;11:996–1007.
   PubMed Web of Science ®Google Scholar
• Kuroda K, Fujimoto N, Tajima S. Abnormal accumulation of inter-alfa-trypsin inhibitor and hyaluronic acid in lichen sclerosus. J Cutan Pathol. 2005;32:137–40.
   Google Scholar
• Farrell AM, Marren P, Dean D, Wojnarowska F. Lichen sclerosus: evidence that immunological changes occur at all levels of the skin. Br J Dermatol. 1999;140:1087–92.
   PubMed Web of Science ®Google Scholar